e-ISSN: Pending
Negative / Null Result ReportOpen accessTherapeutics. Pharmacology

The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study

Asher Shafrir; Asher Shafrir; Asher Shafrir; Ariel A. Benson; Ariel A. Benson; Lior H. Katz; Lior H. Katz; Tiberiu Hershcovici · 2022 · Frontiers in Pharmacology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Background and Aims: There is conflicting evidence regarding the association between proton pump inhibitors (PPI) and the risk of acquisition and severity of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.Aim: To evaluate the association between PPI exposure and infection and development of severe disease in patients infected with SARS-CoV2in a large population-based historical cohort.Methods: Data were extracted from a health maintenance organization database in Israel that insures over 1,200,000 individuals from across the country. All patients who underwent SARS-CoV-2 testi

Abstract by Asher Shafrir; Asher Shafrir; Asher Shafrir; Ariel A. Benson; Ariel A. Benson; Lior H. Katz; Lior H. Katz; Tiberiu Hershcovici, Frontiers in Pharmacology (2022) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.3389/fphar.2022.791074